Renaissance Technologies
YARW

Renaissance Technologies’s Yarrow Bioscience YARW Stock Holding History

Renaissance Technologies’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
466
+120
+35% +$3.89K ﹤0.01% 3114
2026
Q1 		$10.3K Buy
+346
New +$10.1K ﹤0.01% 3197
2025
Q3 		– Sell
-211
Closed -$17.4K – 3986
2025
Q2 		$17.4K Sell
211
-2,092
-91% -$136K ﹤0.01% 3476
2025
Q1 		$182K Buy
2,303
+1,804
+362% +$222K ﹤0.01% 3093
2024
Q4 		$83.6K Sell
499
-1,234
-71% -$161K ﹤0.01% 3314
2024
Q3 		$163K Buy
1,733
+471
+37% +$44.6K ﹤0.01% 3166
2024
Q2 		$124K Sell
1,262
-350
-22% -$43.6K ﹤0.01% 3144
2024
Q1 		$247K Buy
1,612
+684
+74% +$73.7K ﹤0.01% 3157
2023
Q4 		$108K Buy
928
+408
+78% +$63.6K ﹤0.01% 3289
2023
Q3 		$105K Sell
520
-202
-28% -$44.1K ﹤0.01% 3231
2023
Q2 		$148K Buy
722
+210
+41% +$55.9K ﹤0.01% 3364
2023
Q1 		$79K Sell
512
-451
-47% -$81K ﹤0.01% 3558
2022
Q4 		$130K Sell
963
-69
-7% -$13.8K ﹤0.01% 3552
2022
Q3 		$207K Sell
1,032
-12
-1% -$3.84K ﹤0.01% 3370
2022
Q2 		$365K Sell
1,044
-28
-3% -$11.7K ﹤0.01% 3342
2022
Q1 		$627K Buy
1,072
+67
+7% +$39.8K ﹤0.01% 3037
2021
Q4 		$923K Sell
1,005
-378
-27% -$406K ﹤0.01% 2709
2021
Q3 		$1.73M Buy
1,383
+1,038
+301% +$2.01M ﹤0.01% 2202
2021
Q2 		$1.09M Buy
+345
New +$1.37M ﹤0.01% 2630
2021
Q1 		– Sell
-127
Closed -$725K – 3753
2020
Q4 		$725K Buy
+127
New +$798K ﹤0.01% 2659
2020
Q3 		– Sell
-86
Closed -$535K – 3727
2020
Q2 		$535K Buy
+86
New +$582K ﹤0.01% 2852
2020
Q1 		– Sell
-42
Closed -$704K – 3845
2019
Q4 		$704K Buy
42
+7
+20% +$117K ﹤0.01% 2775
2019
Q3 		$559K Buy
35
+4
+13% +$64.6K ﹤0.01% 2831
2019
Q2 		$659K Buy
31
+18
+138% +$445K ﹤0.01% 2882
2019
Q1 		$373K Buy
13
+8
+160% +$192K ﹤0.01% 3032
2018
Q4 		$81K Sell
5
-4
-44% -$89.5K ﹤0.01% 3254
2018
Q3 		$308K Buy
+9
New +$278K ﹤0.01% 3011

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies's YARW Position: Q2 2026 in Review

Renaissance Technologies increased its Yarrow Bioscience (YARW) stake by 35% in Q2 2026, buying an estimated $3.89K and bringing the position to 466 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

Renaissance Technologies first reported a position in YARW in Q3 2018 and has held it in 27 quarters since. The position peaked at $1.73M in Q3 2021. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Renaissance Technologies held 466 shares of Yarrow Bioscience worth $15.2K as of Q2 2026.
  • Renaissance Technologies bought 120 Yarrow Bioscience shares in Q2 2026, an estimated $3.89K.
  • Yarrow Bioscience made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3114 holding.
  • Renaissance Technologies first reported a position in Yarrow Bioscience in Q3 2018 and has held it in 27 quarters since.
  • Renaissance Technologies's Yarrow Bioscience position peaked at $1.73M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.